Search
Patients Pay the Ultimate Price for Price Controls
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
Hochul Doubles Down on Green Bad Deal Policies
Governor Hochul's budget proposal doubles down on ill-advised "Green New Deal" policies.
CCAGW Urges Minnesota House Commerce Committee to Oppose HF 294
HF 294 will create price controls that distort the medical marketplace and impose burdensome restrictions that stifle innovation.
The debt ceiling debate provides no love for taxpayers
The White House and Congress must sit down at the table and do what is necessary to stop the waste and reduce the national debt.
California's Budget Debacle
Poor planning has put California in a perilous financial position.
House Committees Hold Oversight Hearings on COVID-19 Relief Fraud
Long overdue oversight hearings were finally held in the House of Representatives.
CCAGW Urges Senate Judiciary Committee to Oppose S. 150
S. 150 would give the Federal Trade Commission redundant and unnecessary powers.
CCAGW Urges Minnesota Senate Commerce and Consumer Protection Committee to Oppose SF 168
SF 168 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
CCAGW Urges Hawaii Senate Commerce and Consumer Protection Committee to Oppose SB 974
SB 974 will fail to achieve its objective of protecting consumer privacy.
CCAGW Urges Missouri Senate Health and Welfare Committee to Support SB 204
SB 204 would repeal Missouri's outdated certificate-of-need laws.
CCAGW Urges Minnesota House State and Local Government Finance and Policy Committee to Oppose HF 17
HF 17 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
CCAGW Urges Indiana House Government and Regulatory Reform Committee to Support HB 1345
HB 1345 will allow for greater innovation and competition in Missouri by establishing a regulatory sandbox.